NuMed Surgical Inc.
Industry
- Medical Devices
- Surgical Equipment & Devices
- Implantable Devices
Latest on NuMed Surgical Inc.
Global sales for surgical heart valve management products are expected to stay relatively flat by 2023 while percutaneous balloon valvuloplasty (PBV) systems are expected to see double-digit growth, a
Total worldwide sales of heart valve disease treatment systems are set to expand at a compound annual growth rate (CAGR) of 10.9%, increasing from approximately $4,8 billion in 2016 to an estimated $8
US FDA recently formalized class II designations and special controls for six new device types, providing a regulatory roadmap for future devices in the same categories. The classifications resulted f
Demographic changes are one of the key growth factors driving the market for peripheral vascular interventions and diagnostics for peripheral artery disease (PAD). Other factors include new technologi